EP3782612
Samsetningar af sýtidín-hliðstæðum til gjafar um munn og aðferðir til notkunar á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.5.2009EP published:
8.11.2023EP application number:
20201143.3
EP translation filed:
11.12.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
13.5.2029Expiry date:
13.5.2026Next due date:
31.5.2026
Title in English:
ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOFLanguage of the patent:
English
Timeline
Today
14.5.2009EP application
8.11.2023EP Publication
11.12.2023Translation submitted
15.1.2024Registration published
13.5.2026Expires
Owner
Name:
Celgene CorporationAddress:
Route 206 & Province Line Road, 08543, Princeton, NJ, US
Inventor
Name:
ETTER, Jeffrey BAddress:
Boulder, CO Colorado 80302, US
Name:
LAI, MeiAddress:
Longmont, CO Colorado 80504, US
Name:
BACKSTROM, Jay TAddress:
Leawood, KS Kansas 66224, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
5360908 PDate:
15.5.2008Country:
US
Number:
20114508 PDate:
5.12.2008Country:
US
Number:
15787509 PDate:
5.3.2009Country:
US
Classification
Categories:
A61K 9/20, A61K 9/28, A61K 31/7068, A61P 1/00, A61P 1/18, A61P 7/00, A61P 15/08, A61P 35/00, A61P 35/02, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 16
Paid: 5.4.2024
Expires: 13.5.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 5.5.2025
Expires: 13.5.2026
Payer: Árnason Faktor ehf.